Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00628654 · ClinicalTrials.gov registry record
Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 581
- Enrollment target
NCT00628654 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 581 participants.
The verdict
NCT00628654 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 581 participants
- Enrollment target
Study Summary
RATIONALE: New diagnostic procedures, such as glycan analysis, may be effective in finding ovarian epithelial cancer. PURPOSE: This clinical trial is studying how well glycan analysis works in diagnosing cancer in women with ovarian epithelial cancer and in healthy female participants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 581 participants |
| Start Date | 2005-10 |
| Est. Completion | 2016-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00628654
The ClinicalTrials.gov registry entry for NCT00628654 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 581 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00628654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00628654 about?
NCT00628654 is a clinical study titled "Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants". RATIONALE: New diagnostic procedures, such as glycan analysis, may be effective in finding ovarian epithelial cancer. PURPOSE: This clinical trial is studying how well glycan analysis works in diagnosing cancer in women with ovarian epithelial cancer and in healthy female participants.
What is the current status of trial NCT00628654?
This trial is currently completed. The enrollment target is 581 participants. The study started on 2005-10. Estimated completion is 2016-03-10.
Who is sponsoring clinical trial NCT00628654?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.